arrow
H

Hui-Hua Hsiao

kaohsiung medical university hospital
H指数:22
被引数:1,744

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines

探讨全球胃癌实践指南中的异同:对最新台湾指南与亚太、欧洲和美国指南的综述

2026-05-180
OA
Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress–mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma

靶向lncRNA MALAT1通过CD38表观遗传调控、氧化应激介导的细胞死亡以及重塑促肿瘤微环境来缓解来那度胺耐药性,在多发性骨髓瘤中发挥作用。

2025-11-010
OAAI
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort

台湾人群中合并症对新型冠状病毒肺炎疫苗接种血清学反应的影响

2023-06-0216
OAAI
Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody
2022-09-165
OAAI
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan

台湾南部接受硼替佐米加沙利度胺加地塞米松 (VTD) 或硼替佐米加美法仑加泼尼松龙 (VMP) 治疗的不合格骨髓瘤患者的成本效益分析

2022-01-192
OAAI